Healthcare -
Biotechnology - NASDAQ - US
$ 128.0
0.361 %
$ 6.24 B
Market Cap
-21.33
P/E
AXSM - TOTAL CURRENT LIABILITIES
Total Current Liabilities AXSM - Axsome Therapeutics, Inc.
230 M
LAST VALUE
54.37%
2 YEAR CAGR
56.52%
5 YEAR CAGR
72.74%
10 YEAR CAGR